PRIMO[Corporate Author] - Search Results

Year	Number of Results
2001	2
2002	3
2003	1
2004	4
2005	4
2006	6
2007	4
2008	1
2009	5
2010	6
2011	3
2012	7
2013	6
2014	1
2015	5
2016	1
2017	1
2018	5
2019	2
2021	2
2022	1
2023	1
2024	2

1

Immunoblots may not be effective in confirming the recency of HIV-1 infection.

Mariaggi AA, Gardiennet E, Stefic K, Essat A, Cheret A, Goujard C, Meyer L, Barin F, Avettand-Fenoel V; ANRS PRIMO cohort. Mariaggi AA, et al. J Virol Methods. 2021 Apr;290:114074. doi: 10.1016/j.jviromet.2021.114074. Epub 2021 Jan 22. J Virol Methods. 2021. PMID: 33485940

2

Identification of early-induced broadly neutralizing activities against transmitted founder HIV strains.

Lucas J, Lin LY, Paul N, Laumond G, Klingler J, Schmidt S, Frappier J, Essat A, Meyer L, Gordon AC, Goujard CÉC, Bahram S, Moog C; for ANRS CO6 Primo Cohort. Lucas J, et al. AIDS. 2023 Jan 1;37(1):43-49. doi: 10.1097/QAD.0000000000003371. Epub 2022 Sep 16. AIDS. 2023. PMID: 36001527 Free PMC article.

3

High Soluble CD14 Levels at Primary HIV-1 Infection Predict More Rapid Disease Progression.

Krastinova E, Lecuroux C, Leroy C, Seng R, Cabie A, Rami A, Venet A, Meyer L, Goujard C; ANRS PRIMO Cohort. Krastinova E, et al. J Infect Dis. 2015 Sep 15;212(6):909-13. doi: 10.1093/infdis/jiv145. Epub 2015 Mar 6. J Infect Dis. 2015. PMID: 25748321

4

Decreasing proportion of extended-spectrum beta-lactamase among E. coli infections during the COVID-19 pandemic in France.

Lemenand O, Coeffic T, Thibaut S, Colomb Cotinat M, Caillon J, Birgand G; Clinical Laboratories of PRIMO Network. Nantes, France.. Lemenand O, et al. J Infect. 2021 Dec;83(6):664-670. doi: 10.1016/j.jinf.2021.09.016. Epub 2021 Sep 29. J Infect. 2021. PMID: 34600019

5

No evidence of a change in HIV-1 virulence since 1996 in France.

Troude P, Chaix ML, Tran L, Deveau C, Seng R, Delfraissy JF, Rouzioux C, Goujard C, Meyer L; ANRS Primo cohort. Troude P, et al. AIDS. 2009 Jun 19;23(10):1261-7. doi: 10.1097/QAD.0b013e32832b51ef. AIDS. 2009. PMID: 19424055

6

Genotypic drug resistance during HIV-1 primary infection in France (1996-1999): frequency and response to treatment.

Harzic M, Pellegrin I, Deveau C, Chaix ML, Dubeaux B, Garrigue I, Ngo N, Rouzioux C, Goujard C, Hoen B, Sereni D, Delfraissy JF, Meyer L; PRIMO Study Group. Harzic M, et al. AIDS. 2002 Mar 29;16(5):793-6. doi: 10.1097/00002030-200203290-00017. AIDS. 2002. PMID: 11964538 No abstract available.

7

Phenotypic properties of envelope glycoproteins of transmitted HIV-1 variants from patients belonging to transmission chains.

Beretta M, Moreau A, Bouvin-Pley M, Essat A, Goujard C, Chaix ML, Hue S, Meyer L, Barin F, Braibant M; ANRS 06 Primo Cohort. Beretta M, et al. AIDS. 2018 Sep 10;32(14):1917-1926. doi: 10.1097/QAD.0000000000001906. AIDS. 2018. PMID: 29927786

8

Thrombocytopenia during primary HIV-1 infection predicts the risk of recurrence during chronic infection.

Ghosn J, Persoz A, Zitoun Y, Chaix ML, Amri I, Reynes J, Raffi F, Deveau C, Meyer L, Goujard C; ANRS CO6 PRIMO Cohort. Ghosn J, et al. J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):e112-4. doi: 10.1097/QAI.0b013e31825b6fde. J Acquir Immune Defic Syndr. 2012. PMID: 22772349 No abstract available.

9

Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials.

Smith PK, Shernan SK, Chen JC, Carrier M, Verrier ED, Adams PX, Todaro TG, Muhlbaier LH, Levy JH; PRIMO-CABG II Investigators. Smith PK, et al. J Thorac Cardiovasc Surg. 2011 Jul;142(1):89-98. doi: 10.1016/j.jtcvs.2010.08.035. Epub 2010 Sep 28. J Thorac Cardiovasc Surg. 2011. PMID: 20880552 Free article. Clinical Trial.

10

Rate of CD4 decline and HIV-RNA change following HIV seroconversion in men who have sex with men: a comparison between the Beijing PRIMO and CASCADE cohorts.

Huang X, Lodi S, Fox Z, Li W, Phillips A, Porter K, Lutsar I, Kelleher A, Li N, Xu X, Wu H, Johnson AM; Beijing PRIMO cohort study; CASCADE Collaboration in EuroCoord. Huang X, et al. J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):441-6. doi: 10.1097/QAI.0b013e31827f5c9a. J Acquir Immune Defic Syndr. 2013. PMID: 23221982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

66 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year